Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support

Clinical Nutrition

Volumn 29, Issue 4, 2010, Pages 488-491

  Iversen, Per Ole ^a,b   Wisløff, Finn ^a,c   Gulbrandsen, Nina ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Anthropometry; Biomarkers; Health related quality of life; Intensive treatment; Multiple myeloma

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; MELPHALAN; RETINOL; THYROTROPIN; THYROXINE; TRANSFERRIN; VITAMIN D;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GRIP STRENGTH; HUMAN; MALE; MULTIPLE MYELOMA; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; QUALITY OF LIFE; SKINFOLD THICKNESS; THYROID FUNCTION;

ADULT; ANTHROPOMETRY; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BODY SIZE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NUTRITIONAL STATUS; QUALITY OF LIFE; QUESTIONNAIRES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 77955268801     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.12.002     Document Type: Article

References (8)

1. Raab M.S., Podar K., Breitkreutz I., Richardson P.G., Anderson K.C. Multiple myeloma. Lancet 2009, 374:324-339.
2. Cancer in Norway 2007 The Norwegian cancer registry Available at, [Accessed September 25.09.09]. http://www.kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/CiN2007_hele_web.pdf.
3. Gulbrandsen N., Wisloff F., Brinch L., Carlson K., Dahl I.M., Gimsing P., et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001, 18:65-77.
4. Gulbrandsen N., Hjermstad M.J., Wisloff F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004, 72:172-180.
5. Sherman A.C., Coleman E.A., Griffith K., Simonoton S., Hine R.J., Cromer J., et al. Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation. Support Care Cancer 2003, 11:568-574.
6. Smith A., Wisloff F., Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006, 132:410-451.
7. Iversen P.O., Ukrainchenko E., Afanasyev B., Hulbekkmo K., Choukah A., Gulbrandsen N., et al. Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia. Leuk Lymphoma 2008, 49:1916-1924.
8. Sainteny F., Larras-Regard E., Frindel E. Thyroid hormones induce hemopoietic pluripotent stem cell differentiation toward erythropoiesis through the production of pluripoietin-like factors. Exp Cell Res 1990, 187:174-176.